Back to Search

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

Paper Details
Authors:
Slawomir Wojtowicz‐Praga
Jeff Torri
Michael D. Johnson
VM Steen
John B. Marshall
Elizabeth Ness
Rita A. Dickson
Mark Sale
H. S. Rasmussen
Thomas A. Chiodo
Michael Hawkins
Publication Date: 1998-06-01
Protease and Inhibitor MechanismsBiochemistry, Genetics and Molecular BiologyCancer ResearchLife Sciences
Access Restricted

This paper is not available under open access. The publisher restricts full-text distribution.

You may still be able to access it through your institution, request it directly from the author, or view the abstract and citation details.

External Resources

Paper information is provided by public research databases. Summaries are generated to aid understanding and may not reflect the complete scope of the work. For the authoritative version, please refer to the original publication.